744 related articles for article (PubMed ID: 15023854)
1. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
2. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
[TBL] [Abstract][Full Text] [Related]
3. Lipids modulate ligand binding to sulphonylurea receptors.
Klein A; Lichtenberg J; Stephan D; Quast U
Br J Pharmacol; 2005 Aug; 145(7):907-15. PubMed ID: 15895108
[TBL] [Abstract][Full Text] [Related]
4. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
Löffler-Walz C; Hambrock A; Quast U
Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
[TBL] [Abstract][Full Text] [Related]
6. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
7. Binding and effect of K ATP channel openers in the absence of Mg2+.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
Br J Pharmacol; 2003 May; 139(2):368-80. PubMed ID: 12770942
[TBL] [Abstract][Full Text] [Related]
8. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
[TBL] [Abstract][Full Text] [Related]
9. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
Hambrock A; Löffler-Walz C; Kurachi Y; Quast U
Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
[TBL] [Abstract][Full Text] [Related]
10. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
Stephan D; Stauss E; Lange U; Felsch H; Löffler-Walz C; Hambrock A; Russ U; Quast U
Br J Pharmacol; 2005 Apr; 144(8):1078-88. PubMed ID: 15711591
[TBL] [Abstract][Full Text] [Related]
11. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
[TBL] [Abstract][Full Text] [Related]
12. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
13. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
Tammaro P; Ashcroft F
J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
[TBL] [Abstract][Full Text] [Related]
14. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
J Pharmacol Exp Ther; 2001 Dec; 299(3):1049-55. PubMed ID: 11714894
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
[TBL] [Abstract][Full Text] [Related]
17. Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.
Reimann F; Gribble FM; Ashcroft FM
Mol Pharmacol; 2000 Dec; 58(6):1318-25. PubMed ID: 11093769
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.
Manley PW; Löffler-Walz C; Russ U; Hambrock A; Moenius T; Quast U
Br J Pharmacol; 2001 May; 133(2):275-85. PubMed ID: 11350864
[TBL] [Abstract][Full Text] [Related]
19. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
[TBL] [Abstract][Full Text] [Related]
20. Identification and pharmacological characterization of sarcolemmal ATP-sensitive potassium channels in the murine atrial HL-1 cell line.
Fox JE; Jones L; Light PE
J Cardiovasc Pharmacol; 2005 Jan; 45(1):30-5. PubMed ID: 15613976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]